4114 logo

Synmosa Biopharma Corporation Stock Price

TPEX:4114 Community·NT$15.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

4114 Share Price Performance

NT$0
-29.37 (-100.00%)
NT$0
-29.37 (-100.00%)
Price NT$0

4114 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Solid track record with excellent balance sheet and pays a dividend.

1 Risk
2 Rewards

Synmosa Biopharma Corporation Key Details

NT$6.2b

Revenue

NT$3.5b

Cost of Revenue

NT$2.7b

Gross Profit

NT$1.9b

Other Expenses

NT$821.8m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
1.63
43.28%
13.28%
24.3%
View Full Analysis

About 4114

Founded
1959
Employees
n/a
CEO
Zhihui Lin
WebsiteView website
www.synmosa.com.tw

Synmosa Biopharma Corporation, a specialty pharmaceutical company, engages in the manufacturing and sales of various pharmaceuticals and medical devices in Taiwan, China, the United States, Canada, Thailand, Malaysia, Singapore, and internationally. It offers medicines for urology, hormones, oncology, dermatology, cardiovascular, CNS, gastrointestinal, and other areas; and effervescent tables, granules, and nasal sprays. The company is also involved in provision of cosmetics, veterinary drugs, chemical food additives, and beverages; wholesale retail of environmental drugs; and import and export of related businesses. The company was founded in 1959 and is based in Taipei, Taiwan.

Recent 4114 News & Updates

Recent updates

No updates